
The Cigna Group (CI)
- Previous close
301.06 - Open
303.00 - Bid 298.50 x 8000
- Ask --
- Day's range
296.22 - 303.00 - 52-week range
239.51 - 315.47 - Volume
1,325,388 - Avg. Volume
1,646,500 - Market cap (intra-day)
78.426B - Beta (5Y monthly) 0.30
- PE ratio (TTM)
12.56 - EPS (TTM)
23.60 - Earnings date 30 Jul 2026
- Forward dividend & yield 6.24 (2.10%)
- Ex-dividend date 8 Sept 2026
- 1y target est
340.92
The Cigna Group, together with its subsidiaries, provides insurance and related products and services in the United States. It operates through two segments: Evernorth Health Services and Cigna Healthcare. The Evernorth Health Services segment includes Pharmacy Benefit Services and Specialty and Care Services, offering pharmacy benefit management, drug claim adjudication, retail pharmacy network administration, benefit design consultation, drug utilization review, drug formulary management, pharmacy benefits, home delivery pharmacy, specialty pharmacy, specialty pharmaceutical distribution, and clinical programs for whole-person health outcomes. The Cigna Healthcare segment comprises U.S. Healthcare and International Health, delivering comprehensive medical and coordinated solutions such as employer medical plans, individual and family plans, behavioral health, consumer health engagement, dental, pharmacy management, stop-loss insurance, global health care, and local health care solutions, as well as health care benefits for mobile individuals and employees of multinational organizations. The company offers other operations, including corporate-owned life insurance, reinsurance, and certain run-off and non-strategic businesses. The company distributes its products and services through brokers and consultants; directly to employers, unions and other groups, or individuals; and private and public exchanges. The company was formerly known as Cigna Corporation and changed its name to The Cigna Group in February 2023. The company was founded in 1792 and is headquartered in Bloomfield, Connecticut.
www.thecignagroup.com65,669
Full-time employees
31 December
Fiscal year ends
Healthcare
Sector
Healthcare Plans
Industry
Recent news
View morePerformance overview
Trailing total returns as of 29/07/2026, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .
YTD return
1-year return
3-year return
5-year return
Earnings trends
View moreAnalyst insights
View moreStatistics
View moreValuation measures
Market cap
78.43B
Enterprise value
101.53B
Trailing P/E
12.57
Forward P/E
9.75
PEG ratio (5-yr expected)
0.89
Price/sales (ttm)
0.29
Price/book (mrq)
1.86
Enterprise value/revenue
0.37
Enterprise value/EBITDA
8.09
Financial highlights
Profitability and income statement
Profit margin
2.26%
Return on assets (ttm)
4.78%
Return on equity (ttm)
16.27%
Revenue (ttm)
277.89B
Net income avi to common (ttm)
6.29B
Diluted EPS (ttm)
23.60
Balance sheet and cash flow
Total cash (mrq)
7.85B
Total debt/equity (mrq)
72.80%
Levered free cash flow (ttm)
6.92B
Compare
Select to analyse similar companies using key performance metrics; select up to four stocks.








